Open nathaliaraquelx opened 3 years ago
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
Resumo:
Introdução: vantagem potencial de que a resistência viral a uma armadilha do receptor ACE2 também inibiria a capacidade do vírus de entrar por meio da ligação ao receptor de entrada ACE2 usando uma abordagem de engenharia de proteína híbrida computacional e experimental eles melhoraram a afinidade de ligação da ACE2 c/ o RBD da Spike
Resultados:
Esfingolipídio • Esfingolipídios são uma classe de moléculas de lipídios que formam membrana
Paragloboside
Paragloboside is the precursor for P1 antigen, and globoside (P antigen) is the precursor for NOR antigen
Colocar um resumo ou as partes mais importante do abstract (4 linhas máx.) dos seguintes artigos:
[ ] P. Zhou et al., A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).
[ ] J. Huo, A. Le Bas, R. R. Ruza, H. M. E. Duyvesteyn, Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Nat. Struct. Mol. Biol. 27, 846–854 (2020).
[ ] I. Lui et al., Trimeric SARS-CoV-2 spike interacts with dimeric ACE2 with limited intra-spike avidity. https://doi.org/10.1101/2020.05.21.109157 (21 May 2020).
[ ] A. C. Walls et al., Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281–292.e6 (2020).
[ ] J. Lan et al., Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215–220 (2020).
[ ] T. Kortemme, D. Baker, A simple physical model for binding energy hot spots in protein–protein complexes. Proc. Natl. Acad. Sci. U.S.A. 99, 14116–14121 (2002).
[ ] N. Ollikainen, M. R. de Jong, T. Kortemme, Coupling protein side-chain and backbone flexibility improves the re-design of protein-ligand specificity. PLoS Comput. Biol. 11, e1004335 (2015).
[ ] Y. Li et al., Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1. http://biorxiv.org/lookup/doi/10.1101/2020.04.10.032342 (11 April 2020).
[ ] S. Lim, J. E. Glasgow, M. Filsinger Interrante, E. M. Storm, J. R. Cochran, Dual display of proteins on the yeast cell surface simplifies quantification of binding interactions and enzymatic bioconjugation reactions. Biotechnol. J. 12, 1600696 (2017).
[ ] M. C. Julian et al., Co-evolution of affinity and stability of grafted amyloid-motif domain antibodies. Protein Eng. Des. Sel. 28, 339–350 (2015)
[ ] C. Huang, Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology. Curr. Opin. Biotechnol. 20, 692–699 (2009).
[ ] L. T. Dang et al., Receptor subtype discrimination using extensive shape complementary designed interfaces. Nat. Struct. Mol. Biol. 26, 407–414 (2019).